Photodynamic inactivation of methicillin-resistant Staphylococcus aureus by using Giemsa dye as a photosensitizer

Photodiagnosis Photodyn Ther. 2024 Feb:45:103952. doi: 10.1016/j.pdpdt.2023.103952. Epub 2023 Dec 24.

Abstract

The rise of antibiotic-resistant bacteria calls for innovative approaches to combat multidrug-resistant strains. Here, the potential of the standard histological stain, Giemsa, to act as a photosensitizer (PS) for antimicrobial photodynamic inactivation (aPDI) against methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA) strains is reported. Bioassays were performed using various Giemsa concentrations (ranging from 0.0 to 20.0 µM) under 625 nm illumination at a light dose of 30 J cm-2. Remarkably, Giemsa completely inhibited the growth of MSSA and MRSA bacterial colonies for concentrations at 10 µM and higher but exhibited no inhibitory effect without light exposure. Partition coefficient analysis revealed Giemsa's affinity for membranes. Furthermore, we quantified the production of reactive oxygen species (ROS) and singlet oxygen (1O2) to elucidate the aPDI mechanisms underlying bacterial inactivation mediated by Giemsa. These findings highlight Giemsa stain's potential as a PS in aPDI for targeting multidrug-resistant bacteria.

Keywords: Antimicrobial photodynamic inactivation; Giemsa; Methicillin-resistant Staphylococcus aureus; Multidrug-resistant bacteria; Photodynamic Therapy.

MeSH terms

  • Anti-Infective Agents* / therapeutic use
  • Azure Stains / pharmacology
  • Azure Stains / therapeutic use
  • Humans
  • Methicillin-Resistant Staphylococcus aureus*
  • Photochemotherapy* / methods
  • Photosensitizing Agents / pharmacology
  • Photosensitizing Agents / therapeutic use
  • Staphylococcal Infections* / drug therapy
  • Staphylococcus aureus

Substances

  • Photosensitizing Agents
  • Azure Stains
  • Anti-Infective Agents